Clinical
Trials
Finder
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Search
Conditions
Drugs
Locations
Institutions
Guides
Search Trials
Get Alerts
Conditions
Relapsed/Refractory Marginal Zone Lymphoma
Chengdu, Sichuan
Relapsed/Refractory Marginal Zone Lymphoma Clinical Trials in Chengdu, Sichuan
1 recruiting
Chengdu, Sichuan, China
Showing
1–1
of
1
trials
Recruiting
Phase 3
Efficacy and Safety of Orelabrutinib Combined With Rituximab Versus Lenalidomide Combined With Rituximab in Patients With Relapsed/Refractory Marginal Zone Lymphoma
Relapsed/Refractory Marginal Zone Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd.
324 enrolled
19 locations
NCT06082102
Feedback